1
Return

Comparison of methods for assessing effects of risk factors on disease progression in Mendelian randomization under index event bias

delete2026-06-29
delete0
delete
OA
AI
L
Linxuan Zhang
I
Ixavier Alonzo Higgins
Q
Qile Dai
A
Apostolos Gkatzionis
J
Jocelyn Quistrebert
N
Nasir Bashir
G
Gopuraja Dharmalingam
P
Pallav Bhatnagar
D
Dipender Gill
Y
Yushi Liu
S
Stephen Burgess *
DOI:10.1016/j.ajhg.2026.06.004delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Mendelian randomization has emerged as a transformative approach for inferring causal relationships between risk factors and disease outcomes. However, applying Mendelian randomization to disease progression—a critical step in validating therapeutic targets—is hampered by index event bias. This form of selection bias occurs because analyses of disease progression are necessarily restricted to individuals who have already experienced the disease event. Here, we present a comprehensive evaluation of statistical methods designed to mitigate index event bias, including inverse-probability weighting, Heckman’s method, the Slope-Hunter method, and multivariable methods. We compare their performance in simulations and applied examples. Inverse-probability weighting methods reduce bias but require individual-level data and will only fully eliminate bias when the disease event model is correctly specified. The Slope-Hunter method performed poorly in all simulation scenarios, even when its assumptions were fully satisfied. Multivariable methods worked best when including genetic variants that affect the incident disease event. However, if these genetic variants also affect disease progression directly, then the analysis will suffer from pleiotropy. Hence, if the same biological mechanisms affect disease incidence and progression, then multivariable methods will have little utility. In such a case, however, analyses of disease progression are less critical, as conclusions reached from analyses of disease incidence are likely to hold for disease progression. Our findings indicate that no single method is a universal solution to provide reliable results for the investigation of disease progression. Instead, we propose a strategic framework for method selection based on data availability and biological context.
Keywords:
genetic epidemiology
causal inference
index event bias
methods comparison
collider bias
selection bias
Mendelian randomization
disease progression
drug development
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

American Journal of Human Genetics cover
American Journal of Human Genetics
IF:
8.1
Papers:
7.2K
Citations:
3.7W

Organization

S
sequoia genetics
Scholars:
4
Papers: 3
Citations: 0
B
bristol medical school
Scholars:
127
Papers: 70
Citations: 0
E
Eli Lilly and Company
Scholars:
1.6K
Papers: 487
Citations: 51
M
medical research council
Scholars:
28
Papers: 16
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers